Impax Asset Management Group’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154M | Sell |
1,449,736
-15,034
| -1% | -$1.6M | 0.89% | 40 |
|
|
2025
Q1 | $146M | Sell |
1,464,770
-3,040,709
| -67% | -$304M | 0.88% | 40 |
|
|
2024
Q4 | $401M | Sell |
4,505,479
-964,695
| -18% | -$85.9M | 1.82% | 13 |
|
|
2024
Q3 | $457M | Buy |
5,470,174
+815,403
| +18% | +$68.1M | 1.8% | 12 |
|
|
2024
Q2 | $358M | Buy |
4,654,771
+189,705
| +4% | +$14.6M | 1.46% | 16 |
|
|
2024
Q1 | $305M | Buy |
4,465,066
+123,021
| +3% | +$8.41M | 1.17% | 27 |
|
|
2023
Q4 | $250M | Buy |
4,342,045
+80,071
| +2% | +$4.62M | 1.01% | 32 |
|
|
2023
Q3 | $225M | Sell |
4,261,974
-1,774,667
| -29% | -$93.5M | 1% | 31 |
|
|
2023
Q2 | $326M | Sell |
6,036,641
-941,770
| -13% | -$50.8M | 1.31% | 22 |
|
|
2023
Q1 | $348M | Sell |
6,978,411
-45,023
| -0.6% | -$2.25M | 1.46% | 16 |
|
|
2022
Q4 | $324M | Buy |
7,023,434
+402,301
| +6% | +$18.6M | 1.45% | 17 |
|
|
2022
Q3 | $256M | Buy |
6,621,133
+2,132,468
| +48% | +$82.4M | 1.32% | 20 |
|
|
2022
Q2 | $167M | Buy |
+4,488,665
| New | +$167M | 0.82% | 47 |
|